Seeyond decreased its position in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) by 85.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,608 shares of the company’s stock after selling 9,571 shares during the period. Seeyond’s holdings in Ceridian HCM were worth $103,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also made changes to their positions in the company. Capital International Investors bought a new position in shares of Ceridian HCM during the first quarter valued at $366,250,000. Artisan Partners Limited Partnership increased its stake in Ceridian HCM by 312.2% in the fourth quarter. Artisan Partners Limited Partnership now owns 2,196,191 shares of the company’s stock valued at $140,886,000 after purchasing an additional 1,663,456 shares in the last quarter. Vanguard Group Inc. increased its stake in Ceridian HCM by 4.1% in the third quarter. Vanguard Group Inc. now owns 16,591,001 shares of the company’s stock valued at $927,105,000 after purchasing an additional 658,046 shares in the last quarter. Renaissance Technologies LLC increased its stake in Ceridian HCM by 377.0% in the first quarter. Renaissance Technologies LLC now owns 822,000 shares of the company’s stock valued at $56,204,000 after purchasing an additional 649,656 shares in the last quarter. Finally, Marshall Wace LLP increased its stake in Ceridian HCM by 634.7% in the third quarter. Marshall Wace LLP now owns 381,802 shares of the company’s stock valued at $21,336,000 after purchasing an additional 329,833 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on CDAY. Barclays reduced their price objective on shares of Ceridian HCM from $74.00 to $73.00 in a report on Thursday, May 4th. Robert W. Baird boosted their price target on shares of Ceridian HCM from $78.00 to $86.00 and gave the stock an “outperform” rating in a report on Friday, February 10th. TheStreet upgraded shares of Ceridian HCM from a “d+” rating to a “c-” rating in a report on Friday, February 10th. Wells Fargo & Company cut their price target on shares of Ceridian HCM from $75.00 to $65.00 in a report on Thursday, May 4th. Finally, Credit Suisse Group cut their price target on shares of Ceridian HCM from $105.00 to $83.00 in a report on Thursday, May 4th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $78.79.
Ceridian HCM Stock Performance
Ceridian HCM (NYSE:CDAY – Get Rating) last released its quarterly earnings results on Wednesday, May 3rd. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.05). Ceridian HCM had a negative return on equity of 0.02% and a negative net margin of 2.73%. The company had revenue of $370.60 million during the quarter, compared to analysts’ expectations of $360.77 million. As a group, analysts expect that Ceridian HCM Holding Inc. will post 0.35 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Ceridian HCM news, CEO Leagh Erin Turner sold 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $66.26, for a total value of $397,560.00. Following the completion of the transaction, the chief executive officer now owns 245,201 shares of the company’s stock, valued at approximately $16,247,018.26. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, COO Christopher R. Armstrong sold 1,772 shares of the company’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $57.82, for a total value of $102,457.04. Following the completion of the sale, the chief operating officer now owns 123,797 shares of the company’s stock, valued at approximately $7,157,942.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Leagh Erin Turner sold 6,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $66.26, for a total transaction of $397,560.00. Following the completion of the sale, the chief executive officer now directly owns 245,201 shares of the company’s stock, valued at approximately $16,247,018.26. The disclosure for this sale can be found here. Insiders sold a total of 14,640 shares of company stock valued at $958,865 in the last quarter. Corporate insiders own 4.50% of the company’s stock.
Ceridian HCM Company Profile
Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.
Featured Articles
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition
- Tax Software Specialist Vertex In Buy Zone After Base Breakout
- What is a Mutual Fund? How Does it Work?
- How to Choose a Brokerage Account or Online Broker
- BJ’s Restaurants’ Approaching Buy Point As Earnings Surge 150%
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.
